Credit Suisse’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-89,490
Closed -$376K 3316
2023
Q1
$376K Buy
89,490
+15,357
+21% +$64.5K ﹤0.01% 2887
2022
Q4
$446K Buy
74,133
+73,561
+12,860% +$442K ﹤0.01% 2843
2022
Q3
$3K Buy
572
+526
+1,143% +$2.76K ﹤0.01% 3668
2022
Q2
$0 Buy
+46
New ﹤0.01% 4601
2021
Q2
Sell
-14,117
Closed -$41K 3790
2021
Q1
$41K Buy
+14,117
New +$41K ﹤0.01% 3377
2019
Q3
Sell
-12,549
Closed -$11K 3584
2019
Q2
$11K Sell
12,549
-13,761
-52% -$12.1K ﹤0.01% 3411
2019
Q1
$26K Buy
+26,310
New +$26K ﹤0.01% 3343
2018
Q3
Sell
-22,233
Closed -$110K 3571
2018
Q2
$110K Buy
22,233
+11,143
+100% +$55.1K ﹤0.01% 3365
2018
Q1
$43K Buy
+11,090
New +$43K ﹤0.01% 3462
2016
Q4
Sell
-4,419
Closed -$16K 3911
2016
Q3
$16K Sell
4,419
-41,960
-90% -$152K ﹤0.01% 3715
2016
Q2
$158K Buy
46,379
+24,509
+112% +$83.5K ﹤0.01% 3643
2016
Q1
$117K Buy
21,870
+10,179
+87% +$54.5K ﹤0.01% 3504
2015
Q4
$144K Buy
11,691
+1,874
+19% +$23.1K ﹤0.01% 3777
2015
Q3
$143K Sell
9,817
-1,794
-15% -$26.1K ﹤0.01% 3821
2015
Q2
$226K Buy
11,611
+2,633
+29% +$51.3K ﹤0.01% 3872
2015
Q1
$163K Sell
8,978
-1,016
-10% -$18.4K ﹤0.01% 3855
2014
Q4
$236K Buy
9,994
+2,300
+30% +$54.3K ﹤0.01% 3825
2014
Q3
$186K Sell
7,694
-9,707
-56% -$235K ﹤0.01% 3768
2014
Q2
$489K Sell
17,401
-81
-0.5% -$2.28K ﹤0.01% 3420
2014
Q1
$594K Sell
17,482
-29,603
-63% -$1.01M ﹤0.01% 3219
2013
Q4
$899K Buy
47,085
+1,418
+3% +$27.1K ﹤0.01% 2964
2013
Q3
$740K Buy
45,667
+32,328
+242% +$524K ﹤0.01% 2796
2013
Q2
$140K Buy
+13,339
New +$140K ﹤0.01% 3551